A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)
Key Insights
- ALPEK. de's estimated fair value is Mex$12.26 based on 2 Stage Free Cash Flow to Equity
- ALPEK. de's Mex$11.35 share price indicates it is trading at similar levels as its fair value estimate
- The Mex$23.07 analyst price target for ALPEK A is 88% more than our estimate of fair value
Today we will run through one way of estimating the intrinsic value of ALPEK, S.A.B. de C.V. (BMV:ALPEKA) by estimating the company's future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Believe it or not, it's not too difficult to follow, as you'll see from our example!
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
See our latest analysis for ALPEK. de
Crunching The Numbers
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (MX$, Millions) | Mex$6.49b | Mex$6.54b | Mex$4.89b | Mex$4.13b | Mex$3.78b | Mex$3.65b | Mex$3.64b | Mex$3.72b | Mex$3.86b | Mex$4.05b |
Growth Rate Estimate Source | Analyst x2 | Analyst x2 | Est @ -25.28% | Est @ -15.39% | Est @ -8.46% | Est @ -3.62% | Est @ -0.23% | Est @ 2.15% | Est @ 3.81% | Est @ 4.98% |
Present Value (MX$, Millions) Discounted @ 20% | Mex$5.4k | Mex$4.5k | Mex$2.8k | Mex$2.0k | Mex$1.5k | Mex$1.2k | Mex$989 | Mex$839 | Mex$723 | Mex$630 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = Mex$21b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 7.7%. We discount the terminal cash flows to today's value at a cost of equity of 20%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = Mex$4.1b× (1 + 7.7%) ÷ (20%– 7.7%) = Mex$34b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= Mex$34b÷ ( 1 + 20%)10= Mex$5.3b
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is Mex$26b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of Mex$11.4, the company appears about fair value at a 7.4% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at ALPEK. de as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 20%, which is based on a levered beta of 1.618. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for ALPEK. de
- Debt is well covered by earnings and cashflows.
- Dividend is in the top 25% of dividend payers in the market.
- Earnings declined over the past year.
- Annual earnings are forecast to grow faster than the Mexican market.
- Current share price is below our estimate of fair value.
- Dividends are not covered by earnings.
- Annual revenue is expected to decline over the next 3 years.
Next Steps:
Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For ALPEK. de, we've put together three important aspects you should further examine:
- Risks: For example, we've discovered 5 warning signs for ALPEK. de (1 can't be ignored!) that you should be aware of before investing here.
- Future Earnings: How does ALPEK A's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. Simply Wall St updates its DCF calculation for every Mexican stock every day, so if you want to find the intrinsic value of any other stock just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BMV:ALPEK A
ALPEK. de
Alpek, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico and internationally.
Undervalued with adequate balance sheet.